Day: March 6, 2024

AirBoss Reports 4th Quarter and Full Year 2023 Results

AirBoss Reports 4th Quarter and Full Year 2023 Results

NEWMARKET, Ontario, March 06, 2024 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced its fourth quarter and annual results. The Company will host a conference call and webcast to discuss the results on March 7th at 9:00 a.m. ET, the details of which are further below. All dollar amounts are shown in thousands of United States dollars (“US $” or “$”), except per share amounts, unless otherwise noted. Recent Highlights Generated $40.9 million cash from operations during 2023, compared to consuming $30.8 million in 2022; 2023 Adjusted EBITDA1 of $26.8 million on Adjusted Profit1 of $(6.4) million and a loss of $41.7 million; Finished 2023 with a Net Debt to Adjusted EBITDA ratio1 of 3.30x; and Declared a quarterly dividend of C$0.07 per common...

Continue reading

Havila Kystruten AS: Quarterly report for fourth quarter 2023 – corrections

Havila Kystruten AS: Quarterly report for fourth quarter 2023 – corrections

Reference is made to stock exchange release on 28.02.24 where fourth quarter 2023 accounts were released.The numbers for financial items in the P&L account are correct but linked to wrong descriptions.Please find attached updated report where the cash flow analysis and associated text also is updated. ContactsCEO Bent Martini, +47 905 99 650 CFO Aleksander Røynesdal, + 47 413 18 114   Attachment HKYQ423

Continue reading

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

Fourth Quarter 2023 Total Revenues of $277 million, which aligned our Full Year to the mid-point of guidance Full Year 2023 Total Revenues of $1.05 billion, which was the mid-point of guidance Fourth Quarter 2023 Net Loss of $50 million and Adjusted EBITDA of $3 million Issues Q1 2024 and FY 2024 guidance GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2023. “Emergent has a long history of helping protect people around the world from opioid overdose emergencies and chemical, biological and radiological threats. This commitment to public health, together with Emergent’s leadership, give me confidence in the long-term future of the company,” said Joe Papa, President and CEO at Emergent. “Emergent...

Continue reading

NL REPORTS FOURTH QUARTER 2023 RESULTS

NL REPORTS FOURTH QUARTER 2023 RESULTS

Dallas, Texas, March 06, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $7.6 million, or $.16 per share, in the fourth quarter of 2023 compared to a net loss attributable to NL stockholders of $6.1 million, or $.13 per share, in the fourth quarter of 2022. NL’s results include an unrealized gain of $2.4 million in the fourth quarter of 2023 related to the change in value of marketable equity securities compared to a $3.8 million unrealized loss in the fourth quarter of 2022. For the full year of 2023, NL reported a net loss attributable to NL stockholders of $2.3 million, or $.05 per share, compared to net income attributable to NL stockholders of $33.8 million, or $.69 per share for the full year of 2022. NL’s results include an unrealized loss of $8.1 million...

Continue reading

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

– Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia – Development of breakthrough immune-quiet DNA for hemophilia A program continues – Cash balance of $264.4 million expected to fund operations into 2H 2027 CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and fourth quarter and full year 2023 financial results. “Late last year we announced important advances in our cell-targeted lipid nanoparticle and immune-quiet DNA platforms that we are now translating to our portfolio strategy,” said Geoff McDonough, M.D., chief executive officer...

Continue reading

<div>Victoria’s Secret & Co. Reports Fourth Quarter 2023 Results</div>

Victoria’s Secret & Co. Reports Fourth Quarter 2023 Results

Fourth quarter adjusted operating income and adjusted diluted EPS at the high-end of guidance Generated nearly $590 million in operating cash flow in the fourth quarter and ended the year with debt down over $150 million year-over-year Announces new $250 million share repurchase authorization Provides initial full year and first quarter 2024 guidance REYNOLDSBURG, Ohio, March 06, 2024 (GLOBE NEWSWIRE) — Victoria’s Secret & Co. (“Victoria’s Secret” or the “Company”) (NYSE: VSCO) today reported 2023 financial results for the fourth quarter and fiscal year ended February 3, 2024. Chief Executive Officer Martin Waters commented on the fourth quarter, “I am grateful for the hard work and dedication of our team of associates and partners around the world who executed our strategies, delighted our customers and delivered solid financial...

Continue reading

KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2023 RESULTS

KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2023 RESULTS

Dallas, Texas, March 06, 2024 (GLOBE NEWSWIRE) — Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $5.3 million, or $.05 per share, in the fourth quarter of 2023 compared to a net loss of $19.9 million, or $.18 per share, in the fourth quarter of 2022. For the full year of 2023, Kronos Worldwide reported a net loss of $49.1 million, or $.43 per share, compared to net income of $104.5 million, or $.90 per share for the full year of 2022. Net income increased in the fourth quarter of 2023 as compared to the fourth quarter of 2022 primarily due to higher income from operations as a result of the net effect of higher sales volumes, lower average TiO2 selling prices and lower production costs (primarily raw material costs). Net income decreased in the full year of 2023 as compared to the full year 2022 primarily due to...

Continue reading

Omega Flex, Inc. Announces Fourth Quarter 2023 Earnings

Omega Flex, Inc. Announces Fourth Quarter 2023 Earnings

    OMEGA FLEX, INC. (OFLX)     For the Period Ended December 31,     Twelve Months   Three Months                         2023     2022     2023     2022                   Net Sales   $111,465,000   $125,487,000   $28,147,000   $30,817,000                                     Net Income attributable to Omega Flex, Inc.   $20,763,000   $23,622,000   $4,889,000   $6,181,000                                     Earnings Per Share – Basic and Diluted   $2.06   $2.34   $0.48   $0.61                                     Weighted Average Shares – Basic and Diluted     10,094,322     10,094,322     10,094,322     10,094,322                   EXTON, Pa., March 06, 2024 (GLOBE NEWSWIRE) — Dean W. Rivest, CEO, announced that net sales of Omega Flex, Inc. (the “Company” or “Omega Flex”) for 2023 and 2022...

Continue reading

NeoGames Announces Fourth Quarter and Full Year 2023 Results

NeoGames Announces Fourth Quarter and Full Year 2023 Results

– Full Year 2023 Revenues and Share of NPI Revenues Interest total $254.6 million –– Full Year 2023 Net Loss of $18.3 million and Adjusted Net Income, after taking effect of the amortization of Aspire intangibles, was $12.8 million –– Full Year 2023 Adjusted EBITDA total $76.2 million, an increase of 39.8% year-over-year –– Expected Timeline for Completion of the Aristocrat Business Combination during the second quarter 2024 – LUXEMBOURG, March 06, 2024 (GLOBE NEWSWIRE) — NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery and iGaming solutions, announced today financial results for the fourth quarter and year ended December 31, 2023. Moti Malul, Chief Executive Officer of NeoGames, said: “We are very pleased with the progress we made during the fourth quarter and during...

Continue reading

Rush Street Interactive Announces Fourth Quarter and Full Year 2023 Results

Rush Street Interactive Announces Fourth Quarter and Full Year 2023 Results

– Fourth Quarter Revenue of $194 Million, up 17% Year-over-Year –– Full Year 2023 Revenue of $691 Million, up 17% –– Fourth Quarter and Full Year Net Loss of $5.5 Million and $60.1 Million, respectively –– Fourth Quarter and Full Year Adjusted EBITDA of $11.5 Million and $8.2 Million, respectively –– Strong Fourth Quarter 2023 Momentum Reflected in Full Year 2024 Revenue Guidance of Between $770 and $830 Million –– Initiating Full Year 2024 Adjusted EBITDA Guidance of Between $35 and $45 Million – CHICAGO, March 06, 2024 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced financial results for the fourth quarter and full year...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.